Therma Bright, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA8834261080
CAD
0.05
0.03 (150.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Therma Bright, Inc. stock-summary
stock-summary
Therma Bright, Inc.
Pharmaceuticals & Biotechnology
Therma Bright Inc is Canada-based medical technology company, focused on providing consumers with medical devices that address their dermatological needs. The Company's technology delivers non-invasive and pain-free skin care. The Company's focus is to market its products online through social media and to re-establish relationships with North American retailers and to pursue the redesign of its existing platforms and commercialize technologies. The flag product is The Intercept CS Cold Sore Prevention System, which is consisted of an ergonomically designed hand held unit and a disposable treatment activator. The Intercept CS system provides controlled topical heat without the risk of burning the skin. The device’s controlled range of heat naturally prevents cold sore outbreaks.
Company Coordinates stock-summary
Company Details
132-1173 Dundas Street East , TORONTO CA : M4M 3P1
stock-summary
Tel: 1 416 8672353
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Rob Fia
President, Chief Executive Officer, Director
Mr. Joseph Heng
Independent Director
Mr. Spencer Huh
Independent Director
Mr. Tim Peterson
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Apr 2025)
Net Profit:
0 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CAD 4 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.03

stock-summary
Return on Equity

-173.24%

stock-summary
Price to Book

3.73